Quantbot Technologies LP acquired a new stake in Nu Skin Enterprises, Inc. (NYSE:NUS - Free Report) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 99,498 shares of the company's stock, valued at approximately $733,000. Quantbot Technologies LP owned about 0.20% of Nu Skin Enterprises as of its most recent SEC filing.
Several other large investors also recently modified their holdings of NUS. Signaturefd LLC boosted its position in Nu Skin Enterprises by 72.6% during the second quarter. Signaturefd LLC now owns 3,797 shares of the company's stock valued at $40,000 after acquiring an additional 1,597 shares during the last quarter. Canada Pension Plan Investment Board purchased a new stake in Nu Skin Enterprises during the second quarter valued at about $47,000. Public Employees Retirement System of Ohio grew its position in shares of Nu Skin Enterprises by 30.5% in the first quarter. Public Employees Retirement System of Ohio now owns 3,926 shares of the company's stock valued at $54,000 after purchasing an additional 918 shares in the last quarter. GAMMA Investing LLC grew its position in shares of Nu Skin Enterprises by 167.4% during the 2nd quarter. GAMMA Investing LLC now owns 5,734 shares of the company's stock valued at $60,000 after purchasing an additional 3,590 shares in the last quarter. Finally, Lazard Asset Management LLC increased its position in shares of Nu Skin Enterprises by 92.7% in the first quarter. Lazard Asset Management LLC now owns 4,587 shares of the company's stock worth $63,000 after purchasing an additional 2,206 shares during the last quarter. 82.84% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
NUS has been the topic of a number of research analyst reports. Citigroup reduced their price target on Nu Skin Enterprises from $11.50 to $6.75 and set a "neutral" rating on the stock in a report on Tuesday, October 22nd. StockNews.com upgraded Nu Skin Enterprises from a "hold" rating to a "buy" rating in a research report on Monday, November 11th. Finally, DA Davidson dropped their price target on Nu Skin Enterprises from $12.50 to $11.00 and set a "neutral" rating on the stock in a research report on Monday, August 12th.
Read Our Latest Stock Report on Nu Skin Enterprises
Nu Skin Enterprises Price Performance
NUS traded down $0.05 during trading on Tuesday, reaching $7.58. 214,388 shares of the stock were exchanged, compared to its average volume of 847,206. Nu Skin Enterprises, Inc. has a 1 year low of $5.95 and a 1 year high of $20.75. The company has a quick ratio of 1.20, a current ratio of 1.93 and a debt-to-equity ratio of 0.53. The business's 50 day moving average price is $6.78 and its two-hundred day moving average price is $9.27.
Nu Skin Enterprises Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, December 11th. Stockholders of record on Friday, November 29th will be paid a $0.06 dividend. This represents a $0.24 dividend on an annualized basis and a dividend yield of 3.17%. The ex-dividend date is Friday, November 29th. Nu Skin Enterprises's dividend payout ratio is presently -11.59%.
Nu Skin Enterprises Company Profile
(
Free Report)
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
Read More
Before you consider Nu Skin Enterprises, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nu Skin Enterprises wasn't on the list.
While Nu Skin Enterprises currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.